Ligand validation:9MED

AMP: ADENOSINE MONOPHOSPHATE

AMP is a Ligand Of Interest in 9MED designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
9MED_AMP_A_502	84%	43%	0.065	0.924	0.81	1.37	-	2	0	0	100%	1
9MED_AMP_B_501	66%	45%	0.085	0.887	0.78	1.33	1	2	0	0	100%	1
9MED_AMP_D_501	49%	44%	0.089	0.833	0.8	1.33	-	2	0	0	100%	1
9MED_AMP_C_502	38%	44%	0.097	0.794	0.79	1.35	-	2	0	0	100%	1
9MEA_AMP_C_501	82%	44%	0.073	0.928	0.83	1.34	1	2	0	0	100%	1
9MEC_AMP_A_501	62%	39%	0.083	0.873	0.89	1.46	1	3	0	0	100%	1
9MF6_AMP_A_502	56%	58%	0.087	0.856	0.73	0.87	-	1	0	0	100%	1
9MDT_AMP_A_503	49%	43%	0.091	0.834	0.84	1.37	1	2	0	0	100%	1
3LOQ_AMP_A_271	100%	45%	0.039	0.987	0.82	1.3	-	2	2	0	100%	1
7SNB_AMP_A_303	100%	55%	0.045	0.993	0.75	0.98	-	1	0	0	100%	0.783
3FWZ_AMP_B_601	100%	32%	0.037	0.984	1.15	1.55	2	4	0	0	100%	1
4RDH_AMP_C_301	100%	23%	0.039	0.983	1.37	1.79	3	6	0	0	100%	1
3CLT_AMP_C_1262	100%	40%	0.046	0.987	0.91	1.4	1	4	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.